Fmr LLC Seres Therapeutics, Inc. Transaction History

Fmr LLC

  • $1.68 Trillion
  • Q2 2025

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$0.64 - $0.91 $49,750 - $70,738
77,735 Added 0.36%
21,889,432 $15.3 Million
Q4 2024

Feb 13, 2025
SELL
$0.55 - $0.98 $575,059 - $1.02 Million
-1,045,563 Reduced 4.57%
21,811,697 $18.1 Million
Q3 2024

Nov 13, 2024
BUY
$0.7 - $1.48 $98,067 - $207,342
140,096 Added 0.62%
22,857,260 $21.7 Million
Q2 2024

Aug 13, 2024
BUY
$0.56 - $1.19 $36,817 - $78,236
65,745 Added 0.29%
22,717,164 $16.4 Million
Q1 2024

May 13, 2024
BUY
$0.75 - $1.56 $2.45 Million - $5.09 Million
3,262,839 Added 16.83%
22,651,419 $17.4 Million
Q4 2023

Feb 13, 2024
BUY
$0.93 - $2.15 $146,835 - $339,459
157,888 Added 0.82%
19,388,580 $27.1 Million
Q3 2023

Nov 13, 2023
BUY
$2.33 - $5.07 $105,977 - $230,603
45,484 Added 0.24%
19,230,692 $45.8 Million
Q2 2023

Aug 11, 2023
BUY
$4.67 - $6.55 $1.28 Million - $1.79 Million
273,750 Added 1.45%
19,185,208 $91.9 Million
Q1 2023

May 11, 2023
BUY
$4.95 - $6.09 $1.1 Million - $1.36 Million
222,697 Added 1.19%
18,911,458 $107 Million
Q4 2022

Feb 13, 2023
BUY
$5.09 - $9.05 $397,162 - $706,153
78,028 Added 0.42%
18,688,761 $105 Million
Q3 2022

Nov 10, 2022
BUY
$3.5 - $7.2 $33,323 - $68,551
9,521 Added 0.05%
18,610,733 $119 Million
Q2 2022

Aug 12, 2022
BUY
$2.7 - $7.62 $12.8 Million - $36 Million
4,723,347 Added 34.04%
18,601,212 $63.8 Million
Q1 2022

May 13, 2022
BUY
$6.3 - $8.84 $635,008 - $891,027
100,795 Added 0.73%
13,877,865 $98.8 Million
Q4 2021

Feb 14, 2022
BUY
$6.02 - $11.43 $116,095 - $220,427
19,285 Added 0.14%
13,777,070 $115 Million
Q3 2021

Nov 15, 2021
BUY
$5.46 - $22.6 $4.58 Million - $19 Million
838,712 Added 6.49%
13,757,785 $95.8 Million
Q2 2021

Aug 13, 2021
BUY
$18.46 - $24.36 $238 Million - $315 Million
12,919,073 New
12,919,073 $308 Million

Others Institutions Holding MCRB

# of Institutions
9
Shares Held
1.98M
Call Options Held
10K
Put Options Held
0
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $1.92B
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email